NYSE:ELAN
Elanco Animal Health Inc
Elanco Animal Health Inc's revenue grew 6.2% in fiscal 2025 to $4.7B. Free cash flow was $284.0M, 6.0% of revenue.Summary generated from Elanco Animal Health Inc's SEC filings. Latest annual report filed Feb 24, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$4.7B
Revenue growth+6.2%
Revenue, 5-yr CAGR+7.6%
Gross margin55.0%
Operating marginn/a
Net margin−4.9%
ROICn/a
Return on equity−3.7%
Debt / equity0.57
Free cash flow$284.0M
FCF margin6.0%
Share count change−0.2%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4,764 | 4,411 | 4,417 | 4,439 | 4,715 |
| Operating income | n/a | n/a | n/a | n/a | n/a |
| Net income | −483 | −78 | −1,231 | 338 | −232 |
| Free cash flow | 324 | 281 | 131 | 394 | 284 |
Recent filings
- 4Insider transaction report
Oct 6, 2026 - 4Insider transaction report
Oct 6, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 5, 2026 - 8-KResults of operations and financial condition
Aug 5, 2026 - 8-KResults of a shareholder vote
May 27, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 6, 2026 - 8-KResults of operations and financial condition
May 6, 2026 - DEF 14AProxy statement
Apr 8, 2026